Basic Info
  • Factory Location: Lianyungang

    Main Sales Markets: Asia

  • Sample Provided: no

    China GMP

    Form: tablet

    Strength: 20mg, 50mg

    Indication: newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukaemia (CML) in the chronic phase; chronic, accelerated or blast phase CML with resistance or intolerance to prior therapy including imatinib mesilate.

Send your message to this supplier
  • From:
  • To:
    Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service